You are here: Home >Posts Tagged ‘Zyprexa

The Cost of Antipsychotic Zyprexa In Comparison With Conventional Antipsychotics

According to new facts of Value in Health, the newer antipsychotic Zyprexa (Olanzapine) may not result in cost savings comparing with an older, inexpensive generic antipsychotic in treating of schizophrenia disease. It was revealed that despite higher medication costs of Zyprexa tablets the difference in one-year direct total costs between this [...]

Tags: , , , , , ,

  • Digg
  • Del.icio.us
  • StumbleUpon
  • Reddit
  • Twitter
  • RSS

Two Adolescent Indications Of Zyprexa Antipsychotic Medicine

A difficult topic has being discussed by the Committee of experts. The U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee (PDAC) declared that Zyprexa (Olanzapine) drug is effective and safe in treating of schizophrenia or manic or mixed episodes associated with bipolar I disorder in patients aged 13-17 years [...]

Tags: , , , ,

  • Digg
  • Del.icio.us
  • StumbleUpon
  • Reddit
  • Twitter
  • RSS

Effect of CORLUX In Risperdal Treatment

New data received by Corcept Therapeutics (NASDAQ: CORT) demonstrated that adding CORLUX to Risperdal (Risperidone) treatment mitigates the weight gain associated with Risperdal drug.
Generic Risperdal is a well-known kind of schizophrenia medication, that is effective for the treatment of schizophrenia disease and bipolar disorder.
CORLUX, Corcept’s late-stage GRII receptor antagonist, was [...]

Tags: , , , , ,

  • Digg
  • Del.icio.us
  • StumbleUpon
  • Reddit
  • Twitter
  • RSS

Additional facts about Zyprexa (Olanzapine) medication

It is known that Zyprexa (Olanzapine) drug is effective in treating of schizophrenia, acute mixed and manic episodes of bipolar I disorder. This medicine is widely prescribed for adults in the United States.
However, there are some cases to be cautious taking Olanzapine tablets.
First, this kind of schizophrenia medication is not approved for the [...]

Tags: , , ,

  • Digg
  • Del.icio.us
  • StumbleUpon
  • Reddit
  • Twitter
  • RSS